| Financial Year |
March 31 2022 |
| Monetary Funds |
99,570,954.49 |
| Held-for-trading Financial Assets |
10,000,000.00 |
| Notes Receivable |
34,018,054.99 |
| Accounts Receivable |
193,348,280.90 |
| Advances to Suppliers |
115,474,153.58 |
| Other Receivables |
9,100,500.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
318,592,742.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
803,831,608.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
169,149,334.79 |
| Investment Properties |
3,546,218.39 |
| Fixed Assetes |
177,706,189.87 |
| Under-construction Projects |
7,122,441.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,614,041.39 |
| R&D expenses |
-- |
| Goodwill |
360,868.48 |
| Long-Term Deferred and Prepaid Expenses |
986,306.23 |
| Deferred Income Tax Assets |
11,085,978.41 |
| Other Non-Current Assets |
12,249,756.26 |
| Sub-Total of Non-Current Assets |
406,894,926.19 |
| Total Assets |
1,210,726,534.20 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,427,265.40 |
| Accounts Payable |
32,720,615.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
641,749.65 |
| Taxes Payable |
4,711,600.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,905,320.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,253,914.40 |
| Other Current Liabilities |
3,438,782.44 |
| Sub-Total of Current Liabilities |
100,331,907.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,189,721.42 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
42,967,192.18 |
| Total Liabilities |
143,299,099.19 |
| Paid-In Capital(Or Share Stock) |
240,000,000.00 |
| Capital Surplus |
294,644,630.56 |
| Surplus Reserve |
72,860,854.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
370,556,175.06 |
| Minority Stockholder's Interest |
87,754,543.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
979,672,891.72 |
| Owner's Equity（Stockholder's Equity） |
1,067,427,435.01 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,210,726,534.20 |
